Geneticist Dr. Mary-Claire King's work reminds us that some of the most powerful scientific ideas start from a deceptively simple premise.
Many decks talk about “reg risk” and “reimbursement” in a single bullet.
This piece goes deeper:
* How to test “What do regulators think you are?”
* Why coding, coverage, and payment must be separate conversations
* How policy (like orphan incentives or DME categories) can turn path risk into upside
Your unique value proposition isn't ""I'm good at my job."" Everyone in this field is good at their job. It's the specific combination of technical strengths, transferable skills, and differentiators that makes you the right person for a particular problem.
By tracing molecular & anatomical evolution on parallel tracks, she’s reshaped thinking across multiple fields and keeps resurfacing in conversations for very good reasons.
This Science Friday interview is a terrific entry point into her world and why her perspective matters so much right now. podcasts.apple.com/us/podcast/s...
Ideal for investors, operators, and advisors navigating healthcare’s hardest paths.
How do you currently pressure-test a startup’s path before diligence?
thinkingkat.substack.com/publish/post...
My latest article shows you how to find and articulate that combination across biotech, pharma, medtech, and digital health.
#LifeSciences #CareerDevelopment #ThinkingKat
thinkingkat.substack.com/publish/post...
If your “Why now?” story collapses the moment someone asks about codes, waivers, or unit economics…it wasn’t a “Why now?” story.
My latest article offers a four-lever framework to pressure-test timing in early healthcare and life sciences deals.
thinkingkat.substack.com/publish/post...
My Thought Leader Blythe Karow is once again contributing to Med Tech startup traction with a series of interviews with former CMS Chief Medical Officer Dr. Lee Fleisher.
substack.com/home/post/p-...
Audrey Greenberg's post is her personal take on Wharton professor Tiantain Yang's research about how trust underpins success for women in business. Worth a read.
www.linkedin.com/posts/audrey...
